Effects of Low Dose Ketamine Given at Induction of Anesthesia on Postoperative Mood in Patients With Depressive Symptoms View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2015-2016

ABSTRACT

Ketamine has been shown to have an antidepressant effect when given intravenously in doses of 2mg/kg. Ketamine is used as a standard induction drug during general anesthesia. It is known in this instance to decrease postoperative pain. No one has studied whether or not ketamine when given in doses used during general anesthesia (0.5mg/kg intravenous) has an antidepressant effect on surgical patients who suffer from depression. The study is designed to determine whether or not a small dose of ketamine when given at the induction of anesthesia could have an antidepressant effect on surgical patients with depression. Detailed Description Non-pregnant females between the ages of 18-65 who are being admitted for gynecological surgery will be given a bedside Goldberg depression screen as part of their routine preanesthetic assessment. If the patient scores five or above on the Goldberg depression screening, they will be asked if they would like to enroll in the study. Exclusion criteria include uncontrolled hypertension, pregnancy, or allergy to ketamine. Once the patient is consented they will be randomized to one of two groups. Every patient will receive an antianxiety medication Midazolam and a narcotic fentanyl prior to going to the operating room. Group A will receive ketamine 0.5mg/kg intravenous as part of their induction for general anesthesia. Group B will not receive ketamine as part of their anesthetic. All other induction drugs will be at the discretion of the anesthesiologist performing the anesthetic. The patients will be seen by a separate anesthesia provider (who is blinded to the group the patient is in) and the results of the depression screening will be added to the patient's data sheet. The patients will be followed again one week after their surgery either in their hospital room (if still hospitalized) or by phone. They will again be given the Goldberg Depression screen and the data will again be added to their data sheet. Several times during the study and at its conclusion the data will be matched with the patients group in order to assess for adverse events such as suicidal ideations, nausea and vomiting. If adverse events are noted, the study design will be altered to take into account the adverse events. More... »

URL

https://clinicaltrials.gov/show/NCT02422303

Related SciGraph Publications

  • 2013-08. Rapid antidepressant effects: moving right along in MOLECULAR PSYCHIATRY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "description": "Ketamine has been shown to have an antidepressant effect when given intravenously in doses of 2mg/kg. Ketamine is used as a standard induction drug during general anesthesia. It is known in this instance to decrease postoperative pain. No one has studied whether or not ketamine when given in doses used during general anesthesia (0.5mg/kg intravenous) has an antidepressant effect on surgical patients who suffer from depression. The study is designed to determine whether or not a small dose of ketamine when given at the induction of anesthesia could have an antidepressant effect on surgical patients with depression.\n\nDetailed Description\nNon-pregnant females between the ages of 18-65 who are being admitted for gynecological surgery will be given a bedside Goldberg depression screen as part of their routine preanesthetic assessment. If the patient scores five or above on the Goldberg depression screening, they will be asked if they would like to enroll in the study. Exclusion criteria include uncontrolled hypertension, pregnancy, or allergy to ketamine. Once the patient is consented they will be randomized to one of two groups. Every patient will receive an antianxiety medication Midazolam and a narcotic fentanyl prior to going to the operating room. Group A will receive ketamine 0.5mg/kg intravenous as part of their induction for general anesthesia. Group B will not receive ketamine as part of their anesthetic. All other induction drugs will be at the discretion of the anesthesiologist performing the anesthetic. The patients will be seen by a separate anesthesia provider (who is blinded to the group the patient is in) and the results of the depression screening will be added to the patient's data sheet. The patients will be followed again one week after their surgery either in their hospital room (if still hospitalized) or by phone. They will again be given the Goldberg Depression screen and the data will again be added to their data sheet. Several times during the study and at its conclusion the data will be matched with the patients group in order to assess for adverse events such as suicidal ideations, nausea and vomiting. If adverse events are noted, the study design will be altered to take into account the adverse events.", 
        "endDate": "2016-09-01T00:00:00Z", 
        "id": "sg:clinicaltrial.NCT02422303", 
        "keywords": [
          "low dose", 
          "induction", 
          "anesthesia", 
          "in-patient", 
          "depression", 
          "ketamine", 
          "antidepressant effect", 
          "dose", 
          "general anesthesia", 
          "instance", 
          "postoperative pain", 
          "surgical patient", 
          "small dose", 
          "female", 
          "age", 
          "surgical procedure", 
          "assessment", 
          "patient", 
          "depression screening", 
          "exclusion criterion", 
          "uncontrolled hypertension", 
          "pregnancy", 
          "Hypersensitivity", 
          "medication", 
          "narcotic", 
          "room", 
          "discretion", 
          "anesthesiologist", 
          "data sheet", 
          "General Surgery", 
          "hospital room", 
          "phone", 
          "screen", 
          "conclusion", 
          "adverse event", 
          "suicidal ideation", 
          "nausea", 
          "vomiting", 
          "study design"
        ], 
        "name": "Effects of Low Dose Ketamine Given at Induction of Anesthesia on Postoperative Mood in Patients With Depressive Symptoms", 
        "sameAs": [
          "https://app.dimensions.ai/details/clinical_trial/NCT02422303"
        ], 
        "sdDataset": "clinical_trials", 
        "sdDatePublished": "2019-03-07T15:25", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "file:///pack/app/us_ct_data_00018.json", 
        "sponsor": [
          {
            "id": "https://www.grid.ac/institutes/grid.267309.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412489.2", 
            "type": "Organization"
          }
        ], 
        "startDate": "2015-12-01T00:00:00Z", 
        "subjectOf": [
          {
            "id": "sg:pub.10.1038/mp.2013.55", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020864419", 
              "https://doi.org/10.1038/mp.2013.55"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1001/archpsyc.63.8.856", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1029393100"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.jad.2013.11.014", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047001591"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "type": "MedicalStudy", 
        "url": "https://clinicaltrials.gov/show/NCT02422303"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT02422303'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT02422303'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT02422303'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT02422303'


     

    This table displays all metadata directly associated to this object as RDF triples.

    70 TRIPLES      16 PREDICATES      58 URIs      48 LITERALS      1 BLANK NODES

    Subject Predicate Object
    1 sg:clinicaltrial.NCT02422303 schema:about anzsrc-for:3053
    2 schema:description Ketamine has been shown to have an antidepressant effect when given intravenously in doses of 2mg/kg. Ketamine is used as a standard induction drug during general anesthesia. It is known in this instance to decrease postoperative pain. No one has studied whether or not ketamine when given in doses used during general anesthesia (0.5mg/kg intravenous) has an antidepressant effect on surgical patients who suffer from depression. The study is designed to determine whether or not a small dose of ketamine when given at the induction of anesthesia could have an antidepressant effect on surgical patients with depression. Detailed Description Non-pregnant females between the ages of 18-65 who are being admitted for gynecological surgery will be given a bedside Goldberg depression screen as part of their routine preanesthetic assessment. If the patient scores five or above on the Goldberg depression screening, they will be asked if they would like to enroll in the study. Exclusion criteria include uncontrolled hypertension, pregnancy, or allergy to ketamine. Once the patient is consented they will be randomized to one of two groups. Every patient will receive an antianxiety medication Midazolam and a narcotic fentanyl prior to going to the operating room. Group A will receive ketamine 0.5mg/kg intravenous as part of their induction for general anesthesia. Group B will not receive ketamine as part of their anesthetic. All other induction drugs will be at the discretion of the anesthesiologist performing the anesthetic. The patients will be seen by a separate anesthesia provider (who is blinded to the group the patient is in) and the results of the depression screening will be added to the patient's data sheet. The patients will be followed again one week after their surgery either in their hospital room (if still hospitalized) or by phone. They will again be given the Goldberg Depression screen and the data will again be added to their data sheet. Several times during the study and at its conclusion the data will be matched with the patients group in order to assess for adverse events such as suicidal ideations, nausea and vomiting. If adverse events are noted, the study design will be altered to take into account the adverse events.
    3 schema:endDate 2016-09-01T00:00:00Z
    4 schema:keywords General Surgery
    5 Hypersensitivity
    6 adverse event
    7 age
    8 anesthesia
    9 anesthesiologist
    10 antidepressant effect
    11 assessment
    12 conclusion
    13 data sheet
    14 depression
    15 depression screening
    16 discretion
    17 dose
    18 exclusion criterion
    19 female
    20 general anesthesia
    21 hospital room
    22 in-patient
    23 induction
    24 instance
    25 ketamine
    26 low dose
    27 medication
    28 narcotic
    29 nausea
    30 patient
    31 phone
    32 postoperative pain
    33 pregnancy
    34 room
    35 screen
    36 small dose
    37 study design
    38 suicidal ideation
    39 surgical patient
    40 surgical procedure
    41 uncontrolled hypertension
    42 vomiting
    43 schema:name Effects of Low Dose Ketamine Given at Induction of Anesthesia on Postoperative Mood in Patients With Depressive Symptoms
    44 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT02422303
    45 schema:sdDatePublished 2019-03-07T15:25
    46 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    47 schema:sdPublisher N55bf1bc6c4f343e9b82d603cee0a6147
    48 schema:sponsor https://www.grid.ac/institutes/grid.267309.9
    49 https://www.grid.ac/institutes/grid.412489.2
    50 schema:startDate 2015-12-01T00:00:00Z
    51 schema:subjectOf sg:pub.10.1038/mp.2013.55
    52 https://doi.org/10.1001/archpsyc.63.8.856
    53 https://doi.org/10.1016/j.jad.2013.11.014
    54 schema:url https://clinicaltrials.gov/show/NCT02422303
    55 sgo:license sg:explorer/license/
    56 sgo:sdDataset clinical_trials
    57 rdf:type schema:MedicalStudy
    58 N55bf1bc6c4f343e9b82d603cee0a6147 schema:name Springer Nature - SN SciGraph project
    59 rdf:type schema:Organization
    60 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
    61 rdf:type schema:DefinedTerm
    62 sg:pub.10.1038/mp.2013.55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020864419
    63 https://doi.org/10.1038/mp.2013.55
    64 rdf:type schema:CreativeWork
    65 https://doi.org/10.1001/archpsyc.63.8.856 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029393100
    66 rdf:type schema:CreativeWork
    67 https://doi.org/10.1016/j.jad.2013.11.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047001591
    68 rdf:type schema:CreativeWork
    69 https://www.grid.ac/institutes/grid.267309.9 schema:Organization
    70 https://www.grid.ac/institutes/grid.412489.2 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...